Companion Diagnostics
News on companion diagnostics and drug/test co-development.
NGeneBio Receives CE-IVD Mark for NGS-Based Cancer Panel
The firm's accompanying software analyzes companion diagnostic biomarkers such as EGFR, BRAF, KRAS, HER2, and ROS1 genes.
Illumina, Janssen Biotech Form Strategic Partnership to Develop Precision Medicines
The collaboration aims to utilize the sequencing giant's data analytics platforms and lab services to speed up the development of personalized therapies.
AmoyDx, AstraZeneca Collaborate to Develop, Commercialize Companion Diagnostic Tests
The agreement involves the codevelopment of a CDx to identify prostate cancer patients in China, the European Union, and Japan with HRR gene mutations.
FDA Approves FoundationOne CDx for EGFR Inhibitors to Identify EGFR Mutations in NSCLC
The FoundationOne CDx test will be used to identify patients for treatment with FDA-approved EGFR inhibitors.
The company is offering combined germline and somatic cancer testing, and sharing patients' variants identified through that testing in a new research registry.